Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

SANTEN PHARMACEUTICAL CO LTD announces completes asset purchase agreement with respect to acquisition of ophthalmology assets from Merck

Wednesday, 2 Jul 2014 02:00am EDT 

SANTEN PHARMACEUTICAL CO LTD:Completed acquire certain ophthalmology assets from Merck & Co., Inc. on July 2.Santen's payment for the closed transaction totaled approximately $550 million (approximately 56 billion yen).Says details disclosed on May 13. 

Company Quote

0.16 +0.27%
1:29pm EST